Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Share This Author
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- A. Thompson, B. Banwell, Jeffrey A. Cohen
- Medicine, PsychologyThe Lancet Neurology
- 21 December 2017
Multiple Sclerosis Severity Score
- R. Roxburgh, S. Seaman, D. Compston
- Medicine, PsychologyNeurology
- 12 April 2005
TLDR
Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.
- M. Andersson, J. Álvarez-cermeño, U. Wurster
- Medicine, BiologyJournal of neurology, neurosurgery, and…
- 1 August 1994
TLDR
The Rao’s Brief Repeatable Battery and Stroop test: normative values with age, education and gender corrections in an Italian population
- M. Amato, E. Portaccio, M. Trojano
- PsychologyMultiple sclerosis
- 1 November 2006
The Brief Repeatable Battery of Neuropsychological Tests (BRB) is by far the most widely used instrument to estimate cognitive dysfunction in multiple sclerosis (MS) patients. However, the paucity of…
The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review
- R. Marrie, S. Reingold, Nadia Reider
- Psychology, MedicineMultiple sclerosis
- 12 January 2015
TLDR
The prevalence of pain in multiple sclerosis
- C. Solaro, G. Brichetto, G. Mancardi
- Psychology, MedicineNeurology
- 14 September 2004
TLDR
Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis
- M. Sormani, N. de Rossi, M. Salvetti
- Medicine, PsychologyAnnals of neurology
- 21 January 2021
This study was undertaken to assess the impact of immunosuppressive and immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID‐19) in people with multiple sclerosis (PwMS).
Cognitive and psychosocial features of childhood and juvenile MS
- M. Amato, B. Goretti, M. Trojano
- Psychology, MedicineNeurology
- 13 May 2008
TLDR
Computer-assisted rehabilitation of attention in patients with multiple sclerosis: results of a randomized, double-blind trial
- M. Amato, B. Goretti, M. Trojano
- Psychology, MedicineMultiple sclerosis
- 1 January 2014
TLDR
Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome
- E. Millefiorini, C. Gasperini, M. Prencipe
- Medicine, PsychologyJournal of Neurology
- 20 February 1997
TLDR
...
1
2
3
4
5
...